MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

VIVUS Company Profile (NASDAQ:VVUS)

Consensus Ratings for VIVUS (NASDAQ:VVUS) (?)
Ratings Breakdown: 4 Hold Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $1.90 (77.57% upside)

Analysts' Ratings History for VIVUS (NASDAQ:VVUS)
Show:
DateFirmActionRatingPrice TargetActions
5/4/2016JPMorgan Chase & Co.Reiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016WallachBeth CapitalDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2016Needham & Company LLCReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/29/2016RBC CapitalDowngradeOutperform -> Sector Perform$4.00 -> $1.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2014Bank of AmericaReiterated RatingUnderperform$4.00 -> $3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/4/2014Credit SuisseInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/28/2014 forward)
Earnings History for VIVUS (NASDAQ:VVUS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/28/2016        
5/3/2016Q116($0.21)($0.12)$17.97 million$15.32 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/9/2016Q4($0.12)($0.12)$22.90 million$15.34 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2015Q315($0.17)($0.15)$20.24 million$24.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2015Q215($0.23)($0.19)$18.76 million$23.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015Q115($0.22)($0.15)$21.80 million$32.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2015Q414($0.25)($0.25)$20.00 million$21.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2014Q314($0.25)($0.10)$21.90 million$33.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q214($0.28)($0.25)$17.90 million$21.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2014Q114($0.37)($0.15)$11.40 million$36.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2014Q413($0.40)($0.17)$28.20 million$44.06 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2013Q313($0.38)($0.48)$21.78 million$27.38 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2013Q2 2013($0.44)($0.55)$12.76 million$5.53 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2013Q1 2013($0.51)($0.53)$5.22 million$4.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2013Q4 2012($0.44)($0.56)$3.09 million$1.97 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2012Q312($0.34)($0.40)$0.35 million$0.04 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2012($0.23)($0.24)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2012($0.13)($0.20)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/28/2012($0.12)($0.14)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2011($0.12)($0.10)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2011($0.13)($0.20)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2011($0.15)($0.12)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/28/2011($0.22)($0.23)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for VIVUS (NASDAQ:VVUS)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for VIVUS (NASDAQ:VVUS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for VIVUS (NASDAQ:VVUS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
4/7/2016Santosh T VargheseInsiderSell329$1.65$542.85View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2016North Tide Capital, LlcMajor ShareholderBuy2,160$1.40$3,024.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/31/2016North Tide Capital, LlcMajor ShareholderBuy383,300$1.29$494,457.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/28/2016North Tide Capital, LlcMajor ShareholderBuy202,000$1.12$226,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2016North Tide Capital, LlcMajor ShareholderBuy500,000$1.21$605,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/1/2016John L SlebirSVPSell2,973$3.04$9,037.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/8/2015North Tide Capital, LlcMajor ShareholderBuy500,000$3.12$1,560,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/6/2015North Tide Capital, LlcMajor ShareholderBuy476,800$3.04$1,449,472.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015North Tide Capital, LlcMajor ShareholderBuy523,200$2.90$1,517,280.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2014Seth H.Z. FischerCEOBuy3,080$6.07$18,695.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/11/2013Alexander DennerDirectorBuy566,844$8.59$4,869,189.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2013Timothy E MorrisCFOSell10,654$11.95$127,315.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2013Michael J AstrueDirectorBuy10,000$11.96$119,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/27/2013Jon C BiroInsiderBuy2,000$12.85$25,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2013Ernest MarioDirectorBuy15,000$14.68$220,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2012Ernest MarioDirectorBuy5,000$20.75$103,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/10/2012Ernest MarioDirectorBuy20,000$21.74$434,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for VIVUS (NASDAQ:VVUS)
DateHeadline
06/27/16 06:57 PMTwo Stocks within Analysts Review: Pfizer, Inc. (NYSE:PFE) , VIVUS, Inc. (NASDAQ:VVUS) - Street Updates
06/27/16 06:57 PMVIVUS, Inc. (NASDAQ:VVUS) & Williams Companies (NYSE:WMB) Stocks in the News - Wall Street 24
06/27/16 05:54 AMNext Weeks Broker Price Targets For VIVUS, Inc. (NASDAQ:VVUS) - Fiscal Standard
06/26/16 05:53 AMShare Volatility Check for: VIVUS Inc. (NASDAQ:VVUS) - Press Telegraph
06/26/16 05:53 AMRecently Issued Stock Ratings For VIVUS, Inc. (NASDAQ:VVUS) - Fiscal Standard
06/22/16 05:57 AMVIVUS (VVUS) Notified of ANDA Filing for Generic Avanafil Tabs
06/21/16 03:07 PMVIVUS INC Files SEC form 8-K, Other Events -
06/20/16 08:32 AMVIVUS, Inc. (NASDAQ:VVUS) Analyst Price Targets For The Coming Week - Fiscal Standard
06/17/16 04:37 PMETF’s with exposure to VIVUS, Inc. : June 17, 2016 -
06/15/16 07:03 PMEarnings Expectation Watch List: Mitsubishi UFJ Financial Group, Inc. (NYSE:MTU), VIVUS Inc. (NASDAQ:VVUS) - Beacon Chronicle
06/13/16 10:08 AMEye Catching Stocks: VIVUS Inc. (NASDAQ:VVUS), QUALCOMM, Inc. (NASDAQ:QCOM), Southwestern Energy ... - KC Register
06/13/16 10:08 AMVivus - Qsymia Scripts Continue Slow Path - Seeking Alpha
06/06/16 11:24 AMImmunomedics Inc. (NASDAQ:IMMU) Stock Plunges: VIVUS Inc. (NASDAQ:VVUS), Arena Pharmaceuticals, Inc ... - KC Register
06/05/16 09:51 AMVIVUS, Inc. (VVUS) Stock Rating Reaffirmed by JPMorgan Chase & Co. - Let Me Know About This
06/04/16 10:24 AMVIVUS Inc. (NASDAQ:VVUS) Fell -3.85% Afterhours: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Orexigen ... - KC Register
06/03/16 02:48 PMETF’s with exposure to VIVUS, Inc. : June 3, 2016 -
06/02/16 07:46 PMInvestor News: VIVUS, Inc. (NASDAQ:VVUS) faces Investigation over possible Wrongdoing - GroundReport - Investor News: VIVUS, Inc. (NASDAQ:VVUS) faces Investigation over possible WrongdoingGroundReportAn investigation for investors in NASDAQ:VVUS shares was announced over potential breaches of fiduciary duties by certain officers and directors at VIVUS, Inc.. Investors who purchased shares of VIVUS, Inc. (NASDAQ:VVUS) have certain options and ...
06/02/16 07:46 PMBuy, Sell Or Hold Rating For VIVUS, Inc. (NASDAQ:VVUS)? - Share Trading News - Buy, Sell Or Hold Rating For VIVUS, Inc. (NASDAQ:VVUS)?Share Trading NewsVIVUS, Inc. has a 50 day moving average of 1.44 and a 200 day moving average of 1.21. The stock's market capitalization is 131.15M, it has a 52-week low of 0.92 and a 52-week high of 2.61. The share price of the company (NASDAQ:VVUS) was down ...and more »
06/01/16 10:15 AMStock Review and Earnings Check on VIVUS, Inc. (NASDAQ:VVUS) - HNN - Stock Review and Earnings Check on VIVUS, Inc. (NASDAQ:VVUS)HNNInvestors and analysts are typically super focused on company earnings numbers when they are reported. Company earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting VIVUS, Inc. (NASDAQ:VVUS) to ...and more »
05/27/16 05:37 PMVIVUS, Inc. (NASDAQ:VVUS) One-Year Price Target At $7.27 - Investor Newswire - VIVUS, Inc. (NASDAQ:VVUS) One-Year Price Target At $7.27Investor NewswireFirst Call has set a 52-week price target of $7.27 on VIVUS, Inc. (NASDAQ:VVUS) stock after completion of its survey. For the approaching quarter, EPS estimate is set at $-0.11 and for underway fiscal at $-0.48. This estimate for next year is $-0.44 ...and more »
05/27/16 05:37 PMTahithromos LLC Decreased Stake in Vivus INC (NASDAQ:VVUS) by $4.57 Million as Shares Rose - CCH Daily News - Tahithromos LLC Decreased Stake in Vivus INC (NASDAQ:VVUS) by $4.57 Million as Shares RoseCCH Daily NewsTahithromos Llc decreased its stake in Vivus Inc (NASDAQ:VVUS) by 97.12% based on its latest 2016Q1 regulatory filing with the SEC. Tahithromos Llc sold 4.57M shares as the company's stock rose 30.84% with the market. The institutional investor held ...VIVUS, Inc. (NASDAQ:VVUS) Latest Broker ViewsRisers & Fallersall 2 news articles »
05/26/16 10:37 PMInvestor Investigation of VIVUS, Inc. (NASDAQ:VVUS) over Potential Wrongdoing Announced - An investigation on behalf of investors in VIVUS, Inc. (NASDAQ:VVUS) shares over potential wrongdoing at VIVUS, Inc. was announced and NASDAQ:VVUS stockholders should contact the Shareholders Foundation. Investors who purchased shares of VIVUS, Inc ...
05/25/16 05:20 PMVIVUS Inc. (VVUS) Jumps 5.13% on May 24 - Equities.com - VIVUS Inc. (VVUS) Jumps 5.13% on May 24Equities.comVIVUS Inc. (VVUS) was among the biggest gainers on the Russell 2000 for Tuesday May 24 as the stock popped 5.13% to $1.23, representing a gain of $0.06 per share. Some 632,548 shares traded hands on 2,177 trades, compared with an average daily ...How Analysts Feel About VIVUS, Inc. (NASDAQ:VVUS)?Wall Street Hints and Newsall 2 news articles »
05/25/16 08:38 AMHow Analysts Feel About VIVUS, Inc. (NASDAQ:VVUS)? - Wall Street Hints and News - How Analysts Feel About VIVUS, Inc. (NASDAQ:VVUS)?Wall Street Hints and NewsOut of 3 analysts covering Vivus (NASDAQ:VVUS), 0 rate it a “Buy”, 0 “Sell”, while 5 “Hold”. This means 0% are positive. Vivus has been the topic of 3 analyst reports since July 31, 2015 according to StockzIntelligence Inc. Below is a list of VIVUS, Inc.
05/24/16 05:27 PMHold Calls Count For VIVUS, Inc. (NASDAQ:VVUS) At 3 - Stocks Daily - Hold Calls Count For VIVUS, Inc. (NASDAQ:VVUS) At 3Stocks DailyBuy calls count on VIVUS, Inc. (NASDAQ:VVUS)'s stock stands at 0 while Sell recommendations is 1. Hold recommendation is 3. VIVUS, Inc. (NASDAQ:VVUS) has a total of 1 Strong Buy recommendations and 0 Strong Sell advises as of 2016-05-23.and more »
05/23/16 10:18 AMStock Rating Review for VIVUS, Inc. (NASDAQ:VVUS) - Wall Street Hints and News - Stock Rating Review for VIVUS, Inc. (NASDAQ:VVUS)Wall Street Hints and NewsCovering equity analysts presently have a consensus stock rating of 2.8 on shares of VIVUS, Inc. (NASDAQ:VVUS). Covering analysts will often provide Sell, Hold, or Buy recommendations based on their advanced research. This consensus rating is compiled ...and more »
05/23/16 08:01 AMI’m traveling this week, so I’m not able to write a new blog post, but I thought I would share the video of the presentation J. Carlo Cannell and I made at last year’s Stansberry Conference in Las Vegas. I’m scheduled to present at the conf -
05/19/16 05:26 PMToday's Hot List: VIVUS Inc. (NASDAQ:VVUS), Chesapeake Granite Wash Trust (NYSE:CHKR), Provident Financial ... - KC Register - Today's Hot List: VIVUS Inc. (NASDAQ:VVUS), Chesapeake Granite Wash Trust (NYSE:CHKR), Provident Financial ...KC RegisterOn 4 May, VIVUS Inc. (NASDAQ:VVUS) reported a loss of 12 cents per share in the first quarter of 2016, narrower than the year-ago loss of 15 cents and the Zacks Consensus Estimate of a loss of 51 cents per share. On Wednesday VIVUS Inc.
05/19/16 08:40 AMExhibited downward Trend in the past Week: VIVUS Inc.'s (VVUS) - Is stories - Exhibited downward Trend in the past Week: VIVUS Inc.'s (VVUS)Is storiesVIVUS Inc.'s (VVUS) witnessed a loss of -1.74% in recent trading period with closing price of $ 1.13. The company's last traded volume of 0.38 million shares was above it's an average volume of 0.97 million shares. In the trailing 12 months period ...and more »
05/18/16 10:29 PMVIVUS, Inc. (NASDAQ:VVUS) Reports Basic Consolidated EPS At $-0.8959 - Stocks Daily - VIVUS, Inc. (NASDAQ:VVUS) Reports Basic Consolidated EPS At $-0.8959Stocks DailyFor the year ended 2015-12-31 VIVUS, Inc. (NASDAQ:VVUS) reported basic consolidated EPS of $-0.8959. The basic consolidated EPS stood at $-0.8959 for the quarter ended 2015-12-31. Per-share earnings form a part of the distributable profit, which is ...Are Analysts Bullish VIVUS, Inc. (NASDAQ:VVUS) After Last Week?Franklin IndependentVIVUS, Inc. (NASDAQ:VVUS) Updated Broker Price TargetsShare Trading Newsall 4 news articles »
05/18/16 10:01 PMETF’s with exposure to VIVUS, Inc. : May 19, 2016 -
05/18/16 05:22 PMShare Recap and Earnings Focus on VIVUS, Inc. (NASDAQ:VVUS) - Wall Street Hints and News - Share Recap and Earnings Focus on VIVUS, Inc. (NASDAQ:VVUS)Wall Street Hints and NewsAnalysts and investors are usually very focused on company earnings numbers when they are released. Company earnings are a good way to evaluate the profitability of the company. Presently, covering analysts are anticipating VIVUS, Inc. (NASDAQ:VVUS) ...and more »
05/18/16 09:30 AMVIVUS, Inc. (NASDAQ:VVUS) Updated Broker Price Targets - Share Trading News - VIVUS, Inc. (NASDAQ:VVUS) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of VIVUS, Inc. (NASDAQ:VVUS). The latest reports which are currently in issue on Wednesday 18th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, ...Vivus Incorporated (NASDAQ:VVUS) Sellers Covered 0.17% of Their ShortsFranklin Independentall 2 news articles »
05/17/16 03:31 PMVIVUS, Inc. :VVUS-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/17/16 10:31 AMSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of VIVUS Inc. - VVUS - [PR Newswire] - NEW YORK, May 17, 2016 /PRNewswire/ -- Levi & Korsinsky announces it has commenced an investigation of VIVUS Inc. (NASDAQ: VVUS) concerning possible breaches of fiduciary duty by the board of directors ...
05/17/16 09:09 AMVivus - Class Action Attorneys May Be Barking Up The Wrong Tree - is investigating a potential breach of fiduciary duty claim involving the board of directors of VIVUS, Inc. (VVUS). On April 22, 2016, VIVUS's stock price closed at $1.80 per share. On May 3, 2016, VIVUS announced that its revenue for the first quarter of ...
05/16/16 05:07 PMConsensus Rating Review for VIVUS, Inc. (NASDAQ:VVUS) - Wall Street Hints and News - Consensus Rating Review for VIVUS, Inc. (NASDAQ:VVUS)Wall Street Hints and NewsEquity research analysts currently have a consensus rating of 2.8 on shares of VIVUS, Inc. (NASDAQ:VVUS). Sell-side analysts will typically rate a company's stock based on extensive research. These ratings usually translate into a Buy, Sell, or Hold ...and more »
05/16/16 11:53 AMShareholder Alert: Purcell Julie & Lefkowitz LLP Is Investigating VIVUS, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors - [PR Newswire] - NEW YORK, May 16, 2016 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a securities class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of VIVUS, Inc. (VVUS). On May 3, 2016, VIVUS announced that its revenue for the first quarter of 2016 was $15.3 million, far less than the $32.2 million in revenue for the first quarter of 2015. VIVUS's stock price closed at $1.16 per share on May 13, 2016. You may also contact Robert H. Lefkowitz, Esq.
05/10/16 05:40 PMPerformance Recap and Target Perspective on VIVUS, Inc. (NASDAQ:VVUS) - B.O.D.Y Confidential - Performance Recap and Target Perspective on VIVUS, Inc. (NASDAQ:VVUS)B.O.D.Y ConfidentialIn the latest trading session, shares of VIVUS, Inc. (NASDAQ:VVUS) moved -1.50%. In order to gain some further insight on stock performance, we can take a look at the stock price relative to some moving averages. After a recent check, company shares ...and more »
05/10/16 12:04 PMVIVUS INC Financials -
05/09/16 05:33 PMSnapshot of Recent Traded Stocks: Alphatec Holdings, Inc. (NASDAQ:ATEC) , VIVUS, Inc. (NASDAQ:VVUS) - Street Updates - Snapshot of Recent Traded Stocks: Alphatec Holdings, Inc. (NASDAQ:ATEC) , VIVUS, Inc. (NASDAQ:VVUS)Street UpdatesIn the past trading session, VIVUS, Inc. (NASDAQ:VVUS) highlighted downward shift of -2.92% or -0.04 points to $1.33. The company traded a volume of 506.6 thousand shares under average volume of 1.03 million shares. Trailing twelve month period, the ...
05/06/16 05:38 PMBiotechnology Movers: VIVUS Inc. (NASDAQ:VVUS), Sarepta Therapeutics, Inc. (NASDAQ:SRPT), BIND Therapeutics ... - KC Register - Biotechnology Movers: VIVUS Inc. (NASDAQ:VVUS), Sarepta Therapeutics, Inc. (NASDAQ:SRPT), BIND Therapeutics ...KC RegisterOn 4 May, VIVUS Inc. (NASDAQ:VVUS) reported a loss of 12 cents per share in the first quarter of 2016, narrower than the year-ago loss of 15 cents and the Zacks Consensus Estimate of a loss of 51 cents per share. The company's total revenues for the ...
05/06/16 03:12 PMVIVUS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -
05/05/16 05:57 PMIntraday Active Biotech Stocks News: VIVUS Inc. (NASDAQ:VVUS), Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) - Street Register - Intraday Active Biotech Stocks News: VIVUS Inc. (NASDAQ:VVUS), Keryx Biopharmaceuticals Inc. (NASDAQ:KERX)Street RegisterVIVUS Inc. (NASDAQ:VVUS) share price decreased to $1.37 each in the last trading session compared to a prior closing price of $1.5. The last closing price is -1.53% below its 20-day moving average and 3.24% above its 50-day moving average. Shares ...
05/05/16 05:57 PMTake a look at Price Fluctuations: Spectranetics Corporation (NASDAQ:SPNC) , VIVUS, Inc. (NASDAQ:VVUS) - Street Updates - Take a look at Price Fluctuations: Spectranetics Corporation (NASDAQ:SPNC) , VIVUS, Inc. (NASDAQ:VVUS)Street UpdatesVIVUS, Inc. (VVUS) , a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity and sexual health, recently provided a business update and declared its financial results for the ...
05/05/16 03:14 PMVIVUS INC Files SEC form 8-K, Change in Directors or Principal Officers -
05/04/16 10:45 PMVIVUS Inc. (VVUS) Drops 5.06% on May 03 - Equities.com - Street Wise Report (press release) (blog)VIVUS Inc. (VVUS) Drops 5.06% on May 03Equities.comVIVUS Inc. (VVUS) was one of the Russell 2000's biggest losers for Tuesday May 03 as the stock slid 5.06% to $1.50, a loss of $-0.08 per share. Starting at an opening price of $1.58 a share, the stock traded between $1.50 and $1.60 over the course of ...Vivus Beats On EPS - Misses On RevenueSeeking AlphaInvestor's Alert: VIVUS Inc. (VVUS)CWRU ObserverZacks Investment Research Upgrades VIVUS, Inc. (VVUS) to "Hold"Web Breaking NewsEnterprise Leader -Street Wise Report (press release) (blog) -Street Registerall 17 news articles »
05/04/16 05:38 PMVivus Beats On EPS - Misses On Revenue - Seeking Alpha - Street Wise Report (press release) (blog)Vivus Beats On EPS - Misses On RevenueSeeking AlphaVivus (NASDAQ:VVUS) announced its Q1 2016 operations results after the market closed, and the happenings were pretty much as expected for close followers of the company. Vivus posted a narrower loss than outdated expectations and missed on revenue ...Investor's Alert: VIVUS Inc. (VVUS)CWRU ObserverZacks Investment Research Upgrades VIVUS, Inc. (VVUS) to "Hold"Web Breaking NewsVIVUS, Inc. (NASDAQ:VVUS) Yearly EPS Target At $-0.5000Enterprise LeaderStreet Wise Report (press release) (blog) -Street Register -Risers & Fallersall 16 news articles »
05/04/16 09:28 AMVivus downgraded by WallachBeth -
05/04/16 07:09 AMVIVUS (VVUS) Q1 Loss Narrower but Qsymia Sales Decline -
About VIVUS

VIVUS logoVIVUS, Inc. is a biopharmaceutical company. The Company operates in the development and commercialization of therapeutic products segment. It provides over two therapies approved by the Food and Drug Association (FDA), which include Qsymia (phentermine and topiramate extended-release) for chronic weight management and STENDRA (avanafil) for erectile dysfunction (ED). The Company has completed the Phase II studies of Qsymia for the indication of Obstructive Sleep Apnea (OSA) and diabetes. Its Qsymia is available in over 40,000 certified retail pharmacies across the country. Its STENDRA is also approved by the European Commission (EC), under the name, SPEDRA, for the treatment of ED in the Europe. The United States Food and Drug Association approved a Supplemental New Drug Application (sNDA) for STENDRA. STENDRA is indicated to be taken approximately 15 minutes before sexual activity.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: VVUS
  • CUSIP: 92855110
Key Metrics:
  • Previous Close: $1.07
  • 50 Day Moving Average: $1.20
  • 200 Day Moving Average: $1.21
  • P/E Ratio: N/A
  • P/E Growth: -2.86
  • Market Cap: $111.38M
  • Current Quarter EPS Consensus Estimate: $-0.48 EPS
Additional Links:
VIVUS (NASDAQ:VVUS) Chart for Tuesday, June, 28, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha